The importance of the innate immune system in controlling HIV infection and disease.

The innate immune system is the first line of defense against invading pathogens and is particularly important in warding off bacterial and viral infections presenting at the mucosal cell surface. From this primitive immune response, the more sophisticated adaptive immune system was derived. Despite nearly two decades of research directed at inducing adaptive immune responses to HIV, no successful immunological therapy or vaccine has been developed. On the basis of recent observations, it is suggested that instead emphasis should now be placed on the alternative arm of the immune system, the innate immune response. Novel approaches should be developed to elicit this rapidly responding immune activity in HIV infection.

[1]  F. Hecht,et al.  SOCIAL CONTACTS AND LEUKÆMIA-LYMPHOMA: THE PHILADELPHIA CHROMOSOME REARRANGEMENT , 1975, The Lancet.

[2]  D. Nixon,et al.  Cytotoxic T-cell recognition of HIV proteins and peptides. , 1991, AIDS.

[3]  C. Heusser,et al.  Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.

[4]  J. Levy,et al.  Do beta-chemokines have clinical relevance in HIV infection? , 1997, The Journal of clinical investigation.

[5]  R. Siliciano,et al.  Preventing AIDS But Not HIV-1 Infection with a DNA Vaccine , 2000, Science.

[6]  M. Caligiuri,et al.  Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. , 1998, Journal of immunology.

[7]  S. Pestka,et al.  Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes , 1983, International journal of cancer.

[8]  A. Svejgaard,et al.  Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin , 1997, The Lancet.

[9]  A. Syvänen,et al.  Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. , 1998, AIDS research and human retroviruses.

[10]  J. Levy,et al.  CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. , 2000, The Journal of general virology.

[11]  R. Steinman,et al.  Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries? , 2000, The Journal of experimental medicine.

[12]  T. Lint,et al.  Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis , 1990, Journal of virology.

[13]  Berger Ea HIV entry and tropism: the chemokine receptor connection. , 1997 .

[14]  R. Kurth,et al.  CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Tompkins,et al.  Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus , 1996, Journal of virology.

[16]  E. Collisson,et al.  Anti-Feline Immunodeficiency Virus (FIV) Soluble Factor(s) Produced from Antigen-Stimulated Feline CD8+ T Lymphocytes Suppresses FIV Replication , 2000, Journal of Virology.

[17]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[18]  Yufei Wang,et al.  The role of γ δ T cells in generating antiviral factors and β‐chemokines in protection against mucosal simian immunodeficiency virus infection , 2000 .

[19]  M. Moriuchi,et al.  Class I-unrestricted noncytotoxic anti-HTLV-I activity of CD8(+) T cells. , 2000, Blood.

[20]  J. Sullivan,et al.  The human uniqueness of HIV: innate immunity and the viral Tat protein. , 1999, Human immunology.

[21]  F. Gheyas,et al.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.

[22]  K. Sell,et al.  Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys. , 1990, Journal of medical primatology.

[23]  S. Bartz,et al.  γδ T lymphocyte responses to HIV , 1996 .

[24]  J. Levy,et al.  Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. , 1998, Blood.

[25]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[26]  A. Simon,et al.  Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.

[27]  M. Biffi,et al.  References Subscriptions Permissions Email Alerts The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I , 2013 .

[28]  J. Margolick,et al.  HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. , 1996, Journal of immunology.

[29]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[30]  S. Knight Bone-marrow-derived dendritic cells and the pathogenesis of AIDS. , 1996, AIDS.

[31]  J. Levy,et al.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.

[32]  J. Banchereau,et al.  Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo1 , 2000, The Journal of Immunology.

[33]  F. Poccia,et al.  Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. , 1999, The Journal of infectious diseases.

[34]  J. Skurnick,et al.  Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. R. Stiehm,et al.  Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.

[36]  D. Dripps,et al.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. , 1995, The Journal of clinical investigation.

[37]  J. Andersson,et al.  Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. , 2001, The Journal of clinical investigation.

[38]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[39]  H. Ms,et al.  Interferon and human immunodeficiency virus infection. , 1987 .

[40]  D. Cooper,et al.  CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia. , 1999, The Journal of infectious diseases.

[41]  N. Letvin,et al.  Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. , 1988, Journal of immunology.

[42]  Charles R. Brown,et al.  Wide Range of Viral Load in Healthy African Green Monkeys Naturally Infected with Simian Immunodeficiency Virus , 2000, Journal of Virology.

[43]  K. Rosenthal,et al.  Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. , 1995, AIDS research and human retroviruses.

[44]  J. Levy,et al.  Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. , 1991, Cellular immunology.

[45]  Y. Rivière,et al.  CD8+-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription , 2000, Journal of Virology.

[46]  R. Coombs,et al.  Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. , 1992, The Journal of clinical investigation.

[47]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[48]  Y. Monczak,et al.  Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active epstein‐barr virus infection , 1989, Journal of medical virology.

[49]  M. Daucher,et al.  Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Levy,et al.  Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.

[51]  C. Bogdan The function of type I interferons in antimicrobial immunity. , 2000, Current opinion in immunology.

[52]  K. Rosenthal,et al.  Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease , 1994, Clinical and experimental immunology.

[53]  R. Modlin Immunology: A Toll for DNA vaccines , 2000, Nature.

[54]  J. Levy,et al.  CD8+ cells from HIV‐2‐infected baboons control HIV replication , 1997, AIDS.

[55]  K. Lennert,et al.  T-ASSOCIATED PLASMA-CELLS , 1975, The Lancet.

[56]  B. Sha,et al.  Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. , 1996, Journal of immunology.